Delivery Order SPE2DB22D2211-SPE2DB25FSBCY
- Not listed
- This $11,684.52 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for 4,565,384,970 units of Atovaquone-Proguanil 250-100 100S, a prescription anti-malarial medication. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999 between Amerisourcebergen and DLA Troop Support Medical, which provides a comprehensive range of medical...
- This is a $9,452.62 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of atovaquone-proguanil 250-100 mg tablets, a malaria prevention medication, to support military healthcare programs. The contract has a completion date of November 27, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $9,724.39, is for the delivery of Atovaquone-Proguanil 250-100 mg tablets, a pharmaceutical product used to prevent and treat malaria. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999...
- This is a $225,650.88 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Atovaquone-Proguanil 250-100 100s, a malaria medication, with an ultimate completion date of April 28, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
- The Defense Logistics Agency has awarded a firm fixed price delivery order contract worth $56,760.00 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the provision of 4,563,628,854 units of Atovaquone-Proguanil 250-100 mg tablets to support military treatment programs. This delivery order is issued under a larger $999,999,999.00 indefinite delivery contract held by Amerisourcebergen Drug Corp as the prime...
- This is a $1,871.79 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a malaria treatment medication. The delivery order has a completion date of July 11, 2025 and is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp also holds a $999,999,999.00...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $16,425 to Amerisourcebergen Drug Corporation to supply 250-100 count packages of atovaquone-proguanil, an antimalarial medication. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in September 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, this order is consistent with Amerisourcebergen's...
- This is a federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,733.21, is a firm fixed-price delivery order for the supply of Atovaquone-Proguanil 250-100 100s, a malaria treatment medication. The contract is not designated as a set-aside award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a wholly-owned subsidiary of AmerisourceBergen Corporation. The $5,423.00 award is for the provision of Atovaquone-Proguanil 250-100 mg tablets, a prescription antimalarial medication, to support military treatment programs and facilities. The delivery order is part of a larger indefinite delivery contract (IDC) with a ceiling value of $999,999,999.00 that serves as the primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,565,912,417 units of Atovaquone-Proguanil 250-100mg tablets. The contract has a firm-fixed price of $4,079.80 and a completion date of September 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSBCYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $22,857.87 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count). This competitive, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of July 21, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. The medication is an antimalarial pharmaceutical used primarily for malaria prophylaxis and treatment within military and federal healthcare systems. This delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates consistent capability to fulfill competitive procurement requirements across diverse therapeutic domains, positioning the company as a critical vendor for Department of Defense medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.9k | 7/18/25 |